(lp0
S'Celsion Corporation Reports Year End 2016 Financial Results and Provides ... GlobeNewswire  - Mar 16, 2017 LAWRENCEVILLE, N.J., March 16, 2017  -- Celsion Corporation , an oncology drug development company, today announced financial results for the year ended December 31, 2016 and provided an update on its&nbsp;...'
p1
aS'Is Now The Right Time To Catch The Celsion Corporation  Knife? Insider Financial - Feb 23, 2017 Celsion Corporation  has been a tough stock to hold over the last few years. Following a high profile run up, and subsequent collapse, back in early 2013, the company has basically deteriorated in value almost painfully slowly, and despite&nbsp;...Insider Trading Activity Celsion Corporation   Director Bought ... - Market ExclusiveCelsion Corporation : Analyst Rating Changes and PT Levels - Post Analyst'
p2
aS'Celsion Corp. Cancer Medications Insider Buying and Analysis Yahoo Finance - Feb 21, 2017 NEW YORK, NY / ACCESSWIRE / February 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is covering Celsion Corp.  today, in light of recent&nbsp;...'
p3
aS"Why Financial Results for Celsion Corporation  Made No Waves StockNewsUnion - Mar 16, 2017 Celsion Corporation  is a nano-cap biotechnology firm based in Lawrenceville, NJ. Celsion develops cancer treatments.Celsion Corporation  to Report Quarterly Earnings: What's in the ... - Post RegistrarCelsion Corporation : A Detailed Look at its Institutional Ownership - Post Analyst"
p4
aS'Celsion Corporation  EPS Projection At $-0.095 RealistInvestor.com - 9 hours ago Celsion Corporation  is likely to account earnings of $-0.095 for prior quarter, which can come on 2017-05-15.'
p5
aS"What Analysts are Predicting For Amphastar Pharmaceuticals, Inc. (AMPH ... The USA Commerce - Mar 15, 2017 Shares of Amphastar Pharmaceuticals, Inc.  dropped -17.23% to $12.20. During the trading on 03/14/2017, Company's stock ranged from $12.05 to $13.96."
p6
aS'What Analysts are Predicting For Oclaro, Inc. , Celsion Corporation ? The USA Commerce - Mar 17, 2017 While trading at volume above than average, Celsion Corporation  previous 52-week high was $1.78 and moved down -77.27% over the same period, trading at a volume of 15.08 million.Wall Street Movers News- General Motors Company , Celsion Corporation ... - Wall Street Times Stocks to Track: Celsion Corporation  , Acacia Research ... - NYSE Journal '
p7
aS"CELSION CORPORATION  Files An 8-K Results of Operations and ... Market Exclusive - Mar 16, 2017 Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA&nbsp;..."
p8
aS"Buy or Sell? What Analysts Recommends: Celsion Corporation , PharmAthene ... StockNewsJournal - Mar 10, 2017 Investors who are keeping close eye on the stock of Celsion Corporation  established that the company was able to keep return on investment at -60.80 in the trailing twelve month while Reuters data showed that industry's average stands at&nbsp;..."
p9
aS"Today's Brokerage Rating: Celsion Corporation , Inotek Pharmaceuticals ... StockNewsJournal - Mar 14, 2017 Investors who are keeping close eye on the stock of Celsion Corporation  established that the company was able to keep return on investment at -60.80 in the trailing twelve month while Reuters data showed that industry's average stands at&nbsp;...Biotech news that matter for investors: Celsion Corporation (NASDAQ:CLSN ... - The Voice Registrar2 Sizzling Hot Biotechnology Stocks: Celsion Corporation , Inotek ... - The Independent Republic"
p10
a.